When soluble SHH peptides are introduced into a conditioned medium containing cultured human HCC cells, such as HA22T or Sk-Hep1 cells, the cells exhibit increased resistance to radiotherapy. The gene discussed is SHH; the disease is hepatocellular carcinoma.